| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.060 | 3.924 | 0 | 0 | 548 | 0 | 3.154 | 5.208 | 12.255 | 6.310 |
| Total Income - EUR | 33.060 | 3.924 | 0 | 0 | 2.318 | 0 | 3.154 | 25.281 | 13.448 | 6.323 |
| Total Expenses - EUR | 38.697 | 10.996 | 7.318 | 7.045 | 7.342 | 8.288 | 7.332 | 13.973 | 11.515 | 11.659 |
| Gross Profit/Loss - EUR | -5.638 | -7.072 | -7.318 | -7.045 | -5.024 | -8.288 | -4.179 | 11.307 | 1.933 | -5.336 |
| Net Profit/Loss - EUR | -6.630 | -7.112 | -7.318 | -7.045 | -5.047 | -8.288 | -4.210 | 11.054 | 1.799 | -5.525 |
| Employees | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cochirleanu Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.076 | 6.724 | 6.334 | 5.947 | 5.566 | 5.201 | 4.831 | 2.984 | 2.381 | 1.799 |
| Current Assets | 11.488 | 1.269 | -2.983 | -3.871 | 843 | 2.224 | 1.908 | 448 | 5.242 | 703 |
| Inventories | 7 | 7 | 0 | 0 | 0 | 354 | 1.094 | 0 | 41 | 0 |
| Receivables | 416 | 415 | 222 | 215 | 211 | 410 | 202 | 49 | 0 | 0 |
| Cash | 11.065 | 847 | -3.205 | -4.086 | 632 | 1.461 | 612 | 399 | 5.201 | 703 |
| Shareholders Funds | 7.402 | 214 | -7.108 | -14.023 | -18.799 | -26.730 | -30.347 | -19.387 | -17.530 | -22.955 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.162 | 7.779 | 10.459 | 16.099 | 25.208 | 34.155 | 37.086 | 22.820 | 25.153 | 25.457 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Cochirleanu Med S.r.l.